Outlook Therapeutics (OTLK) Current Taxes (2015 - 2026)
Outlook Therapeutics (OTLK) reported Current Taxes of $302000.0 for Q1 2026, down 83.73% year-over-year from $1.9 million in Q1 2025, and little changed quarter-over-quarter from $302000.0 in Q4 2025.
Outlook Therapeutics (OTLK) Current Taxes (2015 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 12 years of Current Taxes data on file, last reported at $302000.0 in Q1 2026.
- Current Taxes for Q1 2026 came in at $302000.0, down 83.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $302000.0 (down 83.73% YoY), and the FY2025 annual result was $302000.0, down 83.73% from the prior year.
- Current Taxes steadied at $302000.0 in Q1 2026 per OTLK's latest filing, from $302000.0 in the prior quarter.
- Over five years, Current Taxes peaked at $1.9 million in Q1 2022 and troughed at $302000.0 in Q3 2025.
- A 5-year average of $1.6 million and a median of $1.9 million in 2022 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2022 and 2025: Current Taxes changed 0.0% in 2022, then plunged 83.73% in 2025.
- A 5-year view of Current Taxes shows it stood at $1.9 million in 2022, then changed by 0.0% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then sank by 83.73% to $302000.0 in 2025, then changed by 0.0% to $302000.0 in 2026.
- Business Quant data shows OTLK's Current Taxes at $302000.0 in Q1 2026, $302000.0 in Q4 2025, and $302000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 10,460.56 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | 302,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 302,000.00 |
| Dec 31, 2025 | 302,000.00 |
| Sep 30, 2025 | 302,000.00 |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 1.86 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Mar 31, 2022 | 1.86 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 1.86 Mn |
| Jun 30, 2021 | 1.86 Mn |